Alpha 2.0
Login Register
» Authors » Cato Jacobs

Cato Jacobs

Explore the profile of Cato Jacobs including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 298
Followers 0
Related Specialties
Critical Care
Microbiology
Biomedical Engineering
Top 10 Co-Authors
Joost Wauters
Lore Vanderbeke
Greet Hermans
Katrien Lagrou
Philippe Meersseman
Stephanie Humblet-Baron
Alexander Wilmer
Simon Feys
Frank L van de Veerdonk
Karin Thevissen
Published In
Crit Care
Am J Respir Crit Care Med
Emerg Infect Dis
J Fungi (Basel)
Front Immunol
Affiliations
Soon will be listed here.
Recent Articles
11.
Atypical response to bacterial coinfection and persistent neutrophilic bronchoalveolar inflammation distinguish critical COVID-19 from influenza
Cambier S, Metzemaekers M, de Carvalho A, Nooyens A, Jacobs C, Vanderbeke L, et al.
JCI Insight . 2021 Nov; 7(1). PMID: 34793331
Neutrophils are recognized as important circulating effector cells in the pathophysiology of severe coronavirus disease 2019 (COVID-19). However, their role within the inflamed lungs is incompletely understood. Here, we collected...
12.
Early oseltamivir reduces risk for influenza-associated aspergillosis in a double-hit murine model
Seldeslachts L, Vanderbeke L, Fremau A, Resendiz-Sharpe A, Jacobs C, Laeveren B, et al.
Virulence . 2021 Sep; 12(1):2493-2508. PMID: 34546839
Invasive pulmonary aspergillosis (IPA) is a life-threatening fungal infection occurring mainly in immunocompromised patients. We recently identified IPA as an emerging co-infection with high mortality in critically ill, but otherwise...
13.
Multinational Observational Cohort Study of COVID-19-Associated Pulmonary Aspergillosis
Janssen N, Nyga R, Vanderbeke L, Jacobs C, Ergun M, Buil J, et al.
Emerg Infect Dis . 2021 Sep; 27(11):2892-2898. PMID: 34519638
We performed an observational study to investigate intensive care unit incidence, risk factors, and outcomes of coronavirus disease-associated pulmonary aspergillosis (CAPA). We found 10%-15% CAPA incidence among 823 patients in...
14.
Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial
Vanderbeke L, Janssen N, Bergmans D, Bourgeois M, Buil J, Debaveye Y, et al.
Intensive Care Med . 2021 May; 47(6):674-686. PMID: 34050768
Purpose: Influenza-associated pulmonary aspergillosis (IAPA) is a frequent complication in critically ill influenza patients, associated with significant mortality. We investigated whether antifungal prophylaxis reduces the incidence of IAPA. Methods: We...
15.
Kinetics of peripheral blood neutrophils in severe coronavirus disease 2019
Metzemaekers M, Cambier S, Blanter M, Vandooren J, de Carvalho A, Malengier-Devlies B, et al.
Clin Transl Immunology . 2021 May; 10(4):e1271. PMID: 33968405
Objectives: Emerging evidence of dysregulation of the myeloid cell compartment urges investigations on neutrophil characteristics in coronavirus disease 2019 (COVID-19). We isolated neutrophils from the blood of COVID-19 patients receiving...
16.
Correction to: International survey on influenza-associated pulmonary aspergillosis (IAPA) in intensive care units: responses suggest low awareness and potential underdiagnosis outside Europe
Thevissen K, Jacobs C, Holtappels M, Toda M, Verweij P, Wauters J
Crit Care . 2020 May; 24(1):186. PMID: 32349786
In the publication of this article [1], there was an error in Fig. 1 which caused that the a, b were switched and 'b' was missing as a caption on...
17.
International survey on influenza-associated pulmonary aspergillosis (IAPA) in intensive care units: responses suggest low awareness and potential underdiagnosis outside Europe
Thevissen K, Jacobs C, Holtappels M, Toda M, Verweij P, Wauters J
Crit Care . 2020 Mar; 24(1):84. PMID: 32160910
No abstract available.